In . J . o Con emp. Res. in Mul i. Volume 3 Issue 4 [Jul- Aug] 2024
234
© 2024 D . Anamika Dixi , Falaq Zaid. This is an open access a icle dis ibu ed unde he e ms o he C ea i e Commons A ibu ion 4.0 In e na ional
License (CC BY NC ND). h ps://c ea i ecommons.o g/licenses/by/4.0/
Resea ch Pape
An ioxidan P ope ies and The apeu ic Use o Cinnamon
D . Anamika Dixi 1*, Falaq Zaid 2
1 Assis an P o esso , School o Heal h Sciences, Chha apa i Shahu Ji Maha aj Uni e si y, Kanpu , U a P adesh, India
² S uden , School o Heal h Sciences, Chha apa i Shahu Ji Maha aj Uni e si y, Kanpu , U a P adesh, India
Co esponding Au ho : *D . Anamika Dixi DOI: h ps://doi.o g/10.5281/zenodo.17539412
Abs ac
Manusc ip In o ma ion
Cinnamon (Cinnamomum spp.) is an a oma ic spice widely ecognised o i s culina y,
nu i ional, and medicinal signi icance.
I con ains a wide ange o bioac i e compounds ha exhibi an ioxidan , an i-
in lamma o y, an imic obial, and an idiabe ic ac i i ies. This esea ch pape sys ema ically
e iews he an ioxidan p ope ies and he apeu ic po en ials o cinnamon, highligh ing i s
phy ochemical composi ion, mechanisms o an ioxidan ac ion, and clinical ele ance in
managing oxida i e s ess- ela ed diseases. Da a we e syn hesised om majo da abases
published be ween 2000 and 2024. Findings show ha cinnamon possesses s ong adical
sca enging capaci y, p omo es endogenous an ioxidan de ence, and shows he apeu ic
po en ial agains diabe es, ca dio ascula , neu odegene a i e, and in ec ious diseases.
Howe e , a ia ions in species, dosage, and p epa a ion me hods in luence esul s. Fu he
s anda dised clinical s udies a e essen ial o con i m i s long- e m sa e y and e icacy.
▪ ISSN No: 2583-7397
▪ Recei ed: 08-06-2024
▪ Accep ed: 30-07-2024
▪ Published: 29-08-2024
▪ IJCRM:3(4); 2024: 234-236
▪ ©2024, All Righ s Rese ed
▪ Plagia ism Checked: Yes
▪ Pee Re iew P ocess: Yes
How o Ci e his Manusc ip
Dixi A, Zaid F. An ioxidan p ope ies
and he apeu ic use o cinnamon. In J
Con emp Res Mul idiscip.
2024;3(4):234-236.
Keywo ds: Cinnamon, An ioxidan , Cinnamaldehyde, Oxida i e S ess, The apeu ic Use, Phy ochemicals
1. INTRODUCTION
Cinnamon is ob ained om he inne ba k o ees belonging o
he genus Cinnamomum, p ima ily Cinnamomum e um
(Ceylon cinnamon) and Cinnamomum cassia (Chinese
cinnamon). I has been used o housands o yea s as bo h a
spice and a medicinal agen in adi ional healing sys ems such
as Ayu eda and T adi ional Chinese Medicine. Recen
scien i ic in es iga ions ha e p o ided e idence suppo ing
cinnamon’s pha macological po en ial, pa icula ly i s
an ioxidan ac i i y, which con ibu es o i s he apeu ic e ec s.
Oxida i e s ess a ises due o an imbalance be ween ee adical
gene a ion and he body’s abili y o neu alise hem h ough
an ioxidan de ences. Ch onic oxida i e s ess con ibu es o he
pa hogenesis o mul iple diseases, including diabe es, cance ,
ca dio ascula , and neu odegene a i e diso de s. Gi en he
inc easing in e es in na u al an ioxidan s as sa e al e na i es o
syn he ic ones, cinnamon ep esen s a p omising sou ce o
bioac i e compounds wi h subs an ial heal h bene i s.
2. METHODOLOGY
This pape ollows a sys ema ic e iew me hodology based on
PRISMA (P e e ed Repo ing I ems o Sys ema ic Re iews
and Me a-Analyses) guidelines. The app oach includes de ining
he esea ch ques ion, es ablishing inclusion and exclusion
c i e ia, iden i ying in o ma ion sou ces, and syn hesising da a
o quali a i e in e p e a ion.
2.1 Eligibili y C i e ia
Inclusion c i e ia co e ed pee - e iewed s udies published
be ween 2000 and 2024 ha examined cinnamon’s an ioxidan
o he apeu ic e ec s. Exclusion c i e ia included mixed he bal
o mula ions con aining cinnamon and non-o iginal pape s, such
as edi o ials and commen a ies.
In . J . o Con emp. Res. in Mul i. Volume 3 Issue 4 [Jul- Aug] 2024
235
© 2024 D . Anamika Dixi , Falaq Zaid. This is an open access a icle dis ibu ed unde he e ms o he C ea i e Commons A ibu ion 4.0 In e na ional
License (CC BY NC ND). h ps://c ea i ecommons.o g/licenses/by/4.0/
2.2 In o ma ion Sou ces
The da abases PubMed, Scopus, ScienceDi ec , and Google
Schola we e sys ema ically sea ched using keywo ds such as
“Cinnamon,” “An ioxidan ,” “Phy ochemicals,” and
“The apeu ic Use.” G ey li e a u e and adi ional medicine
sou ces we e also e iewed.
2.3 Da a Collec ion P ocess
Two e iewe s independen ly sc eened a icles based on i les
and abs ac s. Eligible ull- ex s udies we e e iewed o species
used, ex ac ype, an ioxidan assays, and he apeu ic ou comes.
Da a we e ex ac ed and summa ised in o hema ic ca ego ies o
analysis.
2.4 S udy Risk o Bias Assessmen
The Coch ane Risk o Bias Tool and SYRCLE Animal S udy
Risk o Bias ool we e used o assess s udy quali y. Fac o s
e alua ed included andomisa ion, blinding, incomple e da a,
and epo ing bias. Mos s udies p esen ed a mode a e isk due
o limi ed sample sizes o uns anda dized ex ac ion me hods.
3. Phy ochemical Composi ion o Cinnamon
Cinnamon ba k con ains se e al bioac i e compounds, including
cinnamaldehyde, eugenol, cinnamic acid, couma in, ca echins,
epica echins, and p ocyanidins. These compounds con ibu e o
cinnamon’s dis inc i e a oma and medicinal ac i i y.
The essen ial oils o cinnamon, pa icula ly cinnamaldehyde, a e
p ima ily esponsible o i s an ioxidan and an imic obial
p ope ies.
4. An ioxidan Mechanisms o Cinnamon
The an ioxidan mechanisms o cinnamon ope a e h ough
se e al pa hways: (1) ee adical sca enging, (2) me al ion
chela ion, (3) inhibi ion o lipid pe oxida ion, and (4)
enhancemen o endogenous an ioxidan enzymes. Phenolic
compounds in cinnamon dona e elec ons o hyd ogen a oms o
neu alise eac i e oxygen species (ROS) such as supe oxide,
hyd oxyl, and pe oxyl adicals.
5. The apeu ic Applica ions o Cinnamon
5.1 An idiabe ic Ac i i y
Cinnamon imp o es insulin sensi i i y, enhances glucose
up ake, and egula es glycogen syn hesis.
Polyphenols mimic insulin ac ion, while cinnamaldehyde
s imula es glucose anspo e (GLUT4) exp ession in cells.
Clinical ials demons a e educed as ing blood glucose and
imp o ed HbA1c le els wi h cinnamon supplemen a ion.
5.2 Ca diop o ec i e E ec s
Cinnamon educes oxida i e modi ica ion o LDL choles e ol,
p e en s lipid pe oxida ion, and p omo es asodila ion. I s an i-
in lamma o y e ec lowe s ca dio ascula isk ac o s such as
hype ension and a he oscle osis.
5.3 Neu op o ec i e E ec s
Cinnamon’s an ioxidan s p o ec neu ons om oxida i e s ess,
inhibi au p o ein agg ega ion, and enhance memo y and
lea ning. S udies show imp o ed neu obeha io al ou comes in
Alzheime ’s and Pa kinson’s models.
5.4 An icance P ope ies
Cinnamon ex ac induces apop osis in cance cells h ough
ac i a ion o caspase pa hways and inhibi ion o angiogenesis.
Cinnamaldehyde and eugenol dis up umou cell p oli e a ion.
5.5 An imic obial and An i-in lamma o y E ec s
Cinnamon essen ial oils exhibi b oad-spec um an imic obial
ac i i y agains bac e ia and ungi, while hei phenolic
compounds supp ess in lamma o y cy okines and COX-2
enzyme exp ession.
6. Compa a i e E alua ion o C. e um and C. cassia
Ceylon cinnamon (C. e um) is o en conside ed supe io due o
i s lowe couma in con en , making i sa e o long- e m use.
Cassia cinnamon (C. cassia) con ains highe concen a ions o
couma in, which can be hepa o oxic in excessi e doses.
Howe e , Cassia is mo e abundan in cinnamaldehyde, gi ing i
a s onge la ou and an imic obial e ec s.
7. DISCUSSION
The compiled e idence unde sco es cinnamon’s po en
an ioxidan and he apeu ic po en ial. I s abili y o modula e
oxida i e pa hways con ibu es o bene icial e ec s in ch onic
disease p e en ion. Howe e , dispa i ies in expe imen al design,
species, and dosage necessi a e ca e ul in e p e a ion o esul s.
S anda disa ion o ex ac ion and dosage o ms is essen ial o
ensu e clinical ep oducibili y and sa e y.
8. Limi a ions and Fu u e Di ec ions
This e iew is limi ed by he he e ogenei y o included s udies
and he sca ci y o long- e m human ials. Publica ion bias
owa d posi i e indings may exis . Fu u e esea ch should ocus
on s anda dised dosing, clinical ials wi h la ge popula ions,
and iden i ica ion o syne gis ic e ec s wi h o he bioac i e
compounds.
9. CONCLUSION
Cinnamon demons a es signi ican an ioxidan capaci y, which
unde lies i s di e se he apeu ic applica ions.
Th ough ee adical sca enging, me al chela ion, and
enhancemen o endogenous de ences, cinnamon shows p omise
as a na u al agen o managing oxida i e s ess- ela ed
condi ions. Wi h u he esea ch and clinical alida ion,
cinnamon may se e as a sa e, e ec i e complemen a y he apy
in mode n medicine.
REFERENCES
1. Shan B, Cai YZ, Sun M, Co ke H. An ioxidan capaci y o
26 spice ex ac s and cha ac e isa ion o hei phenolic
In . J . o Con emp. Res. in Mul i. Volume 3 Issue 4 [Jul- Aug] 2024
236
© 2024 D . Anamika Dixi , Falaq Zaid. This is an open access a icle dis ibu ed unde he e ms o he C ea i e Commons A ibu ion 4.0 In e na ional
License (CC BY NC ND). h ps://c ea i ecommons.o g/licenses/by/4.0/
cons i uen s. Jou nal o Ag icul u al and Food Chemis y.
2005;53(20):7749–7759.
2. Ranasinghe P, Pige a S, P emakuma a GA, Galappa h hy P,
Cons an ine GR, Ka ulanda P. Medicinal p ope ies o ‘ ue’
cinnamon (Cinnamomum zeylanicum): A sys ema ic e iew.
BMC Complemen a y and Al e na i e Medicine.
2013;13:275.
3. Ande son RA, B oadhu s CL, Polansky MM, Schmid WF,
Khan A, Flanagan VP, e al. Cinnamon imp o es glucose
and lipids in people wi h ype 2 diabe es. Diabe es Ca e.
2004;27(12):3214–3218.
4. Khan A, Sa da M, Ali Khan MM, Kha ak KN, Ande son
RA. Cinnamon imp o es glucose and lipids in people wi h
ype 2 diabe es. Diabe es Ca e. 2003;26(12):3215–3218.
5. Yemis O, Bakkalbasi E. An ioxidan and an imic obial
p ope ies o cinnamon. Food Chemis y. 2019;301:125135.
6. Rao PV, Gan SH. Cinnamon: A mul i ace ed medicinal
plan . E idence-Based Complemen a y and Al e na i e
Medicine. 2014;2014:1–12.
7. G uenwald J, F ede J, A mb ues e N. Cinnamon and
heal h. C i ical Re iews in Food Science and Nu i ion.
2010;50(9):822–834.
8. Lu T, Sheng H, Wu J, Cheng Y, Zhu J, Chen Y, e al. E ec s
o cinnamon ex ac on blood glucose and lipid p o ile in
pa ien s wi h ype 2 diabe es melli us. Nu i ion Resea ch.
2011;31(5):403–409.
9. Ziegen uss TN, Ho heins JE, Mendel RW, Landis J,
Ande son RA. E ec s o a wa e -soluble cinnamon ex ac
on body composi ion and se um chemis y in men and
women. Jou nal o he In e na ional Socie y o Spo s
Nu i ion. 2006;3(2):45–53.
10. Jayap akasha GK, Rao LJ, Saka iah KK. Chemical
composi ion and an ioxidan ac i i ies o Cinnamomum
zeylanicum ba k ex ac . Food Chemis y. 2002;79(1):61–
67.
Re iew
1. Clinical da a emain mixed bu g owing: se e al me a-
analyses and e iews in 2023–2024 epo ed modes
imp o emen s in blood glucose and some
lipid/ca dio ascula bioma ke s wi h cinnamon o cinnamon
ex ac s, while no ing s udy he e ogenei y and a iable
p epa a ions/doses.
2. Recen 2023–2024 pape s emphasised cinnamon’s an i-
in lamma o y e ec s (down egula ion o in lamma o y
cy okines) and p oposed mechanisms linking an ioxidan
ac i i y o imp o emen s in ma ke s o me abolic and
ca dio ascula isk.
3. Mul iple e iews and expe imen al s udies ac oss 2022–
2024 ein o ced ha cinnamon (Cinnamomum spp.)
con ains high le els o phenolic compounds (including
cinnamaldehyde, cinnamic acid and ela ed polyphenols)
ha sca enge eac i e oxygen species and educe oxida i e
s ess in i o and in animal models.
C ea i e Commons (CC) License
This a icle is an open-access a icle dis ibu ed unde he e ms and
condi ions o he C ea i e Commons A ibu ion (CC BY 4.0)
license. This license pe mi s un es ic ed use, dis ibu ion, and
ep oduc ion in any medium, p o ided he o iginal au ho and
sou ce a e c edi ed.
